NEWS & EVENTS

Latest news and upcoming events

Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus antibody, expanding rare disease portfolio
01 Jul 2026

Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus antibody, expanding rare disease portfolio

Upcoming events

  • Swiss Biotech Day 2026
    4 May - 5 May, 2026
    Zurich

    download

  • Goodwin’s European Summit: 2026 Emerging VC Leaders in Life Sciences
    20 -22 May, 2026
    Malta

    download

  • CFO Forum
    21 - 22 May, 2026
    Málaga

    download

  • BIOSPAIN
    29 September - 1 October, 2026
    Bilbao

    download
Ysios co-leads €27,2million Series B financing of stem cell company Cellerix<
20 Sep 2007

Ysios co-leads €27,2million Series B financing of stem cell company Cellerix

The round was led by two of the most experienced life science investors in Europe, LSP (Netherlands) and Ventech (France).
Ysios Capital Partners Starts Registration as an Independent Biotech Venture Capital Firm in Spain<
13 Sep 2007

Ysios Capital Partners Starts Registration as an Independent Biotech Venture Capital Firm in Spain

Ysios Capital Partners will be raising €65 million for their first fund, Ysios BioFund I.

Newsletter

subscribe

Subscribe to our weekly newsletter for the latest
updates on life sciences investments.